RecruitingNot ApplicableNCT07292389

Examining Valence-based Effects in Self-Monitoring Feedback Messages

Examining Valence-based Effects in Self-monitoring Feedback Messages, in the Development of a Novel Semi-automated Self-monitoring Feedback System for Obesity Treatment

Sponsor

University of Virginia

Enrollment

127 participants

Start Date

Mar 23, 2026

Study Type

INTERVENTIONAL

Conditions

Obesity, Overweight Obesity (Disorder)

Summary

The purpose of this research study is to learn how to identify the most effective ways to provide weekly feedback on participants' progress toward intervention goals during a weight loss program.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Positive Reinforcement and a behavioral approach called Positive Reinforcement + Areas for Change for people with obesity (disorder) and obesity, overweight. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALPositive Reinforcement

Feedback composed by a study interventionist that focuses exclusively on positively reinforcing the participant's progress toward achieving their goals.

BEHAVIORALPositive Reinforcement + Areas for Change

Feedback provided by a study interventionist that combines positive reinforcement of the participant's progress with constructive guidance on areas for improvement to support successful goal attainment.

Locations(1)

University of Virginia

Charlottesville, Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07292389

Related Trials

A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets

NCT076520472 locations

Genetic, Microbiological and Behavioral Factors in Obesity

NCT076501492 locations

Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.

NCT076534121 location

DASH-Obesity: Explainable AI for Family-Centric Personalized Weight Control in Adolescents and Young Adults With Obesity and Chronic Conditions

NCT076383451 location

Efficacy of Center-based Childcare to Mitigate Unhealthy Weight Gain in Preschoolers From Low-income Households During the Summer

NCT075834591 location